{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:49:47Z","timestamp":1762004987027},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s15010-018-1147-z","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T12:12:52Z","timestamp":1526040772000},"page":"487-494","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case\u2013case\u2013control study"],"prefix":"10.1007","volume":"46","author":[{"given":"Mohammed J.","family":"Al-Jaghbeer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Ann","family":"Justo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brandon","family":"Bookstaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hucks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majdi N.","family":"Al-Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"1147_CR1","unstructured":"The 10 leading causes of death in the world, 2000 and 2012. Geneva: World Health Organization. \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/index.html\n                    \n                  . Accessed May 2014"},{"key":"1147_CR2","first-page":"1","volume":"60","author":"SL Murphy","year":"2012","unstructured":"Murphy SL, Xu J, Kochanek KD. Deaths: preliminary data for 2010. Natl Vital Stat Rep. 2012;60:1\u201351.","journal-title":"Natl Vital Stat Rep"},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/518460","volume":"28","author":"D Weber","year":"2007","unstructured":"Weber D, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28:825\u201331.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323\u20139.","journal-title":"JAMA"},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/BF01694348","volume":"18","author":"A Henderson","year":"1992","unstructured":"Henderson A, Kelly W, Wright M. Fulminant primary Pseudomonas aeruginosa pneumonia and septicemia in previously well adults. Intensive Care Med. 1992;18:430\u20132.","journal-title":"Intensive Care Med"},{"key":"1147_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1164\/ajrccm.160.2.9808045","volume":"160","author":"M Ruiz","year":"1999","unstructured":"Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Rerspir Crit Care Med. 1999;160:397\u2013405.","journal-title":"Am J Rerspir Crit Care Med"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s00134-013-3046-1","volume":"39","author":"J Rello","year":"2013","unstructured":"Rello J, Borgatta B, Lisboa T. Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century. Intensive Care Med. 2013;39:2204\u20136.","journal-title":"Intensive Care Med"},{"key":"1147_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcrc.2008.02.001","volume":"23","author":"CM Parker","year":"2008","unstructured":"Parker CM, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day AG, Heyland DK; Canadian Critical Care Trials Group. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care. 2008;23:18\u201326.","journal-title":"J Crit Care"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","volume":"50","author":"V Aloush","year":"2006","unstructured":"Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50:43\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00005382-200201000-00007","volume":"17","author":"RM Shah","year":"2002","unstructured":"Shah RM, Wechsler R, Salazar AM, Spirn PW. Spectrum of CT findings in nosocomial Pseudomonas aeruginosa pneumonia. J Thorac Imaging. 2002;17:53\u20137.","journal-title":"J Thorac Imaging"},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2012.04.007","volume":"73","author":"AC Gales","year":"2012","unstructured":"Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY antimicrobial surveillance program (Latin America, 2008\u20132010). Diagn Microbiol Infect Dis. 2012;73:354\u201360.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1378\/chest.130.3.787","volume":"130","author":"JR Beardsley","year":"2006","unstructured":"Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130:787\u201393.","journal-title":"Chest"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/1120009X.2016.1154684","volume":"29","author":"BJ Ereshefsky","year":"2017","unstructured":"Ereshefsky BJ, Al-Hasan MN, Gokun Y, Martin CA. Comparison of \u00df-lactams plus aminoglycosides versus \u00df-lactams plus fluoroquinolones empirical antimicrobial therapy in serious nosocomial infections due to Gram-negative bacilli. J Chemother. 2017;29:30\u20137.","journal-title":"J Chemother"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O\u2019Grady NP, Bartlett JG, Carratal\u00e0 J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinic Infect Dis. 2016;63:e61\u2013e111.","journal-title":"Clinic Infect Dis"},{"key":"1147_CR15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27\u201372.","journal-title":"Clin Infect Dis"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"Guidelines for the management of","year":"2005","unstructured":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Thoracic Society, Infectious Diseases Society of America. Am J Respir Crit Care Med 2005;171:388\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/archinte.164.6.637","volume":"164","author":"PM Houck","year":"2004","unstructured":"Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004;164:637\u201344.","journal-title":"Arch Intern Med"},{"key":"1147_CR18","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1001\/jama.1997.03550230056037","volume":"278","author":"TP Meehan","year":"1997","unstructured":"Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, Weber GF, Petrillo MK, Houck PM, Fine JM. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080\u20134.","journal-title":"JAMA"},{"key":"1147_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJMcp1214869","volume":"370","author":"RG Wunderink","year":"2014","unstructured":"Wunderink RG, Waterer GW. Community-acquired pneumonia. N Engl J Med. 2014;370:543\u201351.","journal-title":"N Engl J Med"},{"key":"1147_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, M\u00fcller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Sch\u00fcnemann HJ; ATS\/ERS\/JRS\/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"1147_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"AF Barker","year":"2002","unstructured":"Barker AF. Bronchiectasis. N Engl J Med. 2002;346:1383\u201393.","journal-title":"N Engl J Med"},{"key":"1147_CR22","unstructured":"General best practice guidelines for immunization: altered immunocompetence. Centers for Disease Control and Prevention. \n                    https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html\n                    \n                  . Accessed 21 Feb 2018"},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerder MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377\u201382.","journal-title":"Thorax"},{"key":"1147_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","volume":"176","author":"J Baggs","year":"2016","unstructured":"Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med. 2016;176:1639\u201348.","journal-title":"JAMA Intern Med"},{"key":"1147_CR25","first-page":"352","volume":"6","author":"LK Logan","year":"2017","unstructured":"Logan LK, Gandra S, Mandal S, Klein EY, Levinson J, Weinstein RA, Laxminarayan R. Prevention Epicenters Program, US Centers for Disease Control and Prevention. Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in children, United States, 1999\u20132012. J Pediatric Infect Dis Soc. 2017;6:352\u20139.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"1147_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jhin.2011.05.007","volume":"79","author":"AG Venier","year":"2011","unstructured":"Venier AG, Gruson D, Lavigne T, Jarno P, L\u2019h\u00e9riteau F, Coignard B, Savey A, Rogues AM. REA-RAISIN group. Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN. J Hosp Infect. 2011;79:44\u20138.","journal-title":"J Hosp Infect"},{"key":"1147_CR27","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","volume":"162","author":"F Arancibia","year":"2002","unstructured":"Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med. 2002;162:1849\u201358.","journal-title":"Arch Intern Med"},{"key":"1147_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s15010-007-7162-0","volume":"36","author":"G Madeddu","year":"2008","unstructured":"Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection. 2008;36:231\u20136.","journal-title":"Infection"},{"key":"1147_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1164\/ajrccm.160.2.9812034","volume":"160","author":"J Rello","year":"1999","unstructured":"Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med. 1999;160:608\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"1147_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.diagmicrobio.2016.09.017","volume":"87","author":"KL Hammer","year":"2017","unstructured":"Hammer KL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Differential effect of prior \u03b2-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017;87:87\u201391.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1147_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amjmed.2008.03.034","volume":"121","author":"HS Cheong","year":"2008","unstructured":"Cheong HS, Kang CI, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med. 2008;121:709\u201314.","journal-title":"Am J Med"},{"issue":"5","key":"1147_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/596709","volume":"48","author":"V Schechner","year":"2009","unstructured":"Schechner V, Nobre V, Kaye KS, et al. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis. 2009;48(5):580\u20136.","journal-title":"Clin Infect Dis"},{"key":"1147_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1086\/381550","volume":"38","author":"E Paramythiotou","year":"2004","unstructured":"Paramythiotou E, Lucet JC, Timsit JF, Vanjak D, Paugam-Burtz C, Trouillet JL, Belloc S, Kassis N, Karabinis A, Andremont A. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis. 2004;38:670\u20137.","journal-title":"Clin Infect Dis"},{"key":"1147_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10096-009-0850-1","volume":"29","author":"M Montero","year":"2010","unstructured":"Montero M, Sala M, Riu M, Belvis F, Salvado M, Grau S, Horcajada JP, Alvarez-Lerma F, Terradas R, Orozco-Levi M, Castells X, Knobel H. Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study. Eur J Clin Microbiol Infect Dis. 2010;29:335\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1147_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhin.2012.10.005","volume":"83","author":"A Nakamura","year":"2013","unstructured":"Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Kondo S, Tabe Y, Ohsaka A. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2013;83:153\u20135.","journal-title":"J Hosp Infect"},{"key":"1147_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13054-015-0916-7","volume":"19","author":"N Cobos-Trigueros","year":"2015","unstructured":"Cobos-Trigueros N, Sol\u00e9 M, Castro P, Torres JL, Hern\u00e1ndez C, Rinaudo M, Fern\u00e1ndez S, Soriano \u00c1, Nicol\u00e1s JM, Mensa J, Vila J, Mart\u00ednez JA. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care. 2015;19:218.","journal-title":"Crit Care"},{"key":"1147_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/cid\/civ447","volume":"61","author":"R Banerjee","year":"2015","unstructured":"Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61:1071\u201380.","journal-title":"Clin Infect Dis"},{"key":"1147_CR38","first-page":"e00189","volume":"16","author":"PB Bookstaver","year":"2017","unstructured":"Bookstaver PB, Nimmich EB, Smith TJ 3rd, Justo JA, Kohn J, Hammer KL, Troficanto C, Albrecht HA, Al-Hasan MN. Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections. Antimicrob Agents Chemother. 2017;16:e00189\u201317.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-018-1147-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T19:21:59Z","timestamp":1557516119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-018-1147-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1007\/s15010-018-1147-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MJA, JAJ, WO, JK, JH: no conflicts. MNA and PBB: Continuing medical education steering committee for Rockpointe Corporation, Columbia, MD, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}